Growth Metrics

Zimmer Biomet Holdings (ZBH) Accumulated Expenses (2016 - 2026)

Zimmer Biomet Holdings has reported Accumulated Expenses over the past 17 years, most recently at $293.9 million for Q1 2026.

  • For Q1 2026, Accumulated Expenses changed N/A year-over-year to $293.9 million; the TTM value through Mar 2026 reached $293.9 million, changed N/A, while the annual FY2025 figure was $477.1 million, 32.47% down from the prior year.
  • Accumulated Expenses for Q1 2026 was $293.9 million at Zimmer Biomet Holdings, down from $477.1 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $706.5 million in Q4 2024 and troughed at $184.5 million in Q1 2022.
  • A 5-year average of $360.3 million and a median of $315.0 million in 2022 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: tumbled 37.3% in 2022 and later skyrocketed 69.38% in 2024.
  • Year by year, Accumulated Expenses stood at $336.2 million in 2022, then increased by 24.06% to $417.1 million in 2023, then skyrocketed by 69.38% to $706.5 million in 2024, then plummeted by 32.47% to $477.1 million in 2025, then crashed by 38.4% to $293.9 million in 2026.
  • Business Quant data shows Accumulated Expenses for ZBH at $293.9 million in Q1 2026, $477.1 million in Q4 2025, and $706.5 million in Q4 2024.